Pages that link to "Item:Q3800950"

The following pages link to Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification (Q3800950):

Displaying 16 items.

• Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (Q1937208) (← links)
• On lachin'S formulae for sample sizes of survival tests (Q3135333) (← links)
• Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance (Q3445311) (← links)
• Sample Size Estimation for Survival Outcomes in Cluster‐Randomized Studies with Small Cluster Sizes (Q4667491) (← links)
• Information and information fractions for design and sequential monitoring of clinical trials (Q4843737) (← links)
• Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691) (← links)
• Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time (Q5861550) (← links)
• On the empirical choice of the time window for restricted mean survival time (Q6047753) (← links)
• Sample size estimation for cancer randomized trials in the presence of heterogeneous populations (Q6055721) (← links)
• Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions (Q6085898) (← links)
• Optimal number of accrual groups and accrual group sizes in longitudinal trials with discrete-time survival endpoints (Q6552780) (← links)
• Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution (Q6560575) (← links)
• Determining sample sizes for combined incident and prevalent cohort studies with and without follow-up (Q6580636) (← links)
• Design and monitoring of survival trials in complex scenarios (Q6625542) (← links)
• Predicting study duration in clinical trials with a time-to-event endpoint (Q6627788) (← links)
• Cost-efficient clinical studies with continuous time survival outcomes (Q6628146) (← links)